Meta Pixel

News and Announcements

Finding the Right Investor For Your Startup

  • Published December 07, 2022 5:11AM UTC
  • Publisher Osama Hassan
  • Categories Capital Raising Tips

“I’m after ‘strategic’ investors!”

This is a statement that I’ve often heard from founders seeking to raise capital for their startup. If you’re a founder who can relate, then consider the following five broad categories of venture capitalists as a useful paradigm to help you pick the right type of investor for your business.

Thematic Investors

Study trends and scour the field to arrive at their own theses about where the big opportunities lie.

Pro: Bring outspoken strategic input and market intelligence to your venture.

Con: They may prefer their own judgement on such things over yours.

Domain Investors

Usually have business experience in a particular industry, such as health care, semi-conductors, or financial services (“fintech”).

Pro: Bring a wealth of industry experience and connections to your venture.

Con: They may be prisoners to their own experience and resistant to your new, industry-disrupting ideas.

Quant Investors

Given the rise of big data, social media and online tracking, these venture capitalists are aggressive and don’t need to know much more about your business than the numbers.

Pro: Quant investors are diligent students of growth and can bring that perspective and those skills to your business, helping you to use all the available digital growth tools to full advantage.

Con: They often have little operating instincts and provide help with strategy or execution.

People Investors

Rely on the ability to judge the quality and character of people by listening to entrepreneurs explaining their vision for solving particular problems.

Pro: They value talent highly and are anxious to invest themselves in you and your team.

Con: People Investors might not be particularly expert at any one thing that you need.

Growth Investors

They specialise in later-stage ventures, and are generally strong financial analysts who run detailed models to test business plan sensitivities.

Pro: Since they’re adept financial architects, they can be very helpful in preparing your company for eventual liquidity.

Con: Growth Investors tend to be analysts, not operators, and their input is skewed accordingly.

Any of these venture capitalists can be the “strategic” or “successful” board member, partner, or investor for you depending on fit and chemistry. Just know what type you want, so you know how to extract the most value from them.

Click here to view the original Linkedin post.

Looking for a platform to raise capital? Click here to discover how Wholesale Investor can help you.

Your capital engagement platform

With a 14-year track record, a network of 32,000+ investors, and a capital raising platform, Wholesale investor is a leading investment platform for start-ups, scale-ups, emerging growth companies, and small caps.

Company Updates
The Biofilm Breakthrough: How An Australian BioTech Firm Is Tapping Indonesia’s $45,000-a-Kitchen Bottleneck

Australian sustainability and deep-tech firm Altair International Pty Ltd is commercialising plant-based clinical hygiene technology, targeting a prime operational bottleneck in Indonesia’s massive national free meals program. Every few years, an Australian deep-tech company emerges combining proprietary science with a transformational anchor contract, the kind of business that quietly creates an entirely new market category […]

Capital Insights
THE TAX CHANGED. NOW THE PRODUCT IS CHANGING TO MATCH.

Changes to the 50% capital gains tax discount are shifting Australian private capital away from growth and into high-yielding wrappers. Fund managers are actively redesigning products across private credit and property to capture the incoming capital rotation

Capital Insights
The Algorithm Re-Dosing Cancer Treatment: Inside the University of Melbourne Spin-Out Rewriting a 60-Year-Old Formula

Oncology specialists are still calculating toxic chemotherapy doses using a formula from the era of the Ford Model T, leading to a system where seven out of eight patients are routinely overdosed. University of Melbourne spin-out PredicTx is dismantling this legacy approach, utilizing advanced AI to analyze existing patient CT scans, deliver precision medicine to the bedside, and return a massive 100x financial rerate to hospital networks.

Join over 45,000+ sophisticated investors

Join Now